PR95-27-014. Clinical evaluation of PROCRIT in the treatment of anemic cancer patients receiving chemotherapy,
Role: Investigator,
Ortho Biotech. Inc.,
(03/1996 - 03/1997)
Status: Completed
Non-Profit Organization
(Bristol/Theradex) A phase II trial of paclitaxel (taxol) administered as a weekly one hour infusion in previously treated patients with head and neck cancers,
Role: Investigator,
Bristol-Myers Squibb Foundation, Inc.,
(10/2000 - 10/2001)
Status: Completed